Analysis

CrowdStrike Surges 10%, Closing in on Wedbush's $250 Target

CrowdStrike shares surged nearly 10% to $227, almost reaching Wedbush's new $250 target. The rally follows strong quarterly results and a bullish analyst note, but high valuation and stock-based compensation remain concerns.

Daniel Marsh · · · 3 min read · 9 views
CrowdStrike Surges 10%, Closing in on Wedbush's $250 Target
Mentioned in this article
CRWD $206.74 -1.02%

CrowdStrike Holdings (NASDAQ: CRWD) experienced a sharp rally on Monday, with shares climbing nearly 10% in early trading to reach $227.36. This surge brought the stock within 10% of Wedbush's new price target of $250, a level that previously implied a 21% upside from Friday's close of $206.74. The move occurred despite a broader market dip, as the Nasdaq Composite fell 1.2% amid a selloff in chipmakers.

The rally was notable for its speed and magnitude, with shares hitting an intraday high of $227.40 by 9:59 a.m. Eastern time. Trading volume was robust, exceeding 5.1 million shares in the first half-hour. However, the surge was not accompanied by any new company-specific announcements or SEC filings, leaving investors to rely on existing fundamentals and analyst commentary.

Wedbush's Bullish Stance

Wedbush initiated coverage on CrowdStrike with an Outperform rating and a $250 price target last week, citing accelerated annual recurring revenue (ARR) growth and strong net-new ARR additions. The analyst note highlighted the company's momentum in the cybersecurity sector, particularly its AI-driven security platform. The target now appears less generous after Monday's rally, but it still offers a potential 10% upside from current levels.

Valuation at a Glance

At the current price, CrowdStrike's market capitalization stands at approximately $232.8 billion, based on 1.024 billion shares outstanding as of August 20. This translates to roughly 39.6 times the annualized revenue from the latest quarter, which totaled $1.47 billion. While this multiple is demanding, it reflects the market's confidence in the company's growth trajectory. The company reported fiscal second-quarter revenue growth of 26% year-over-year, with ending ARR up 25% to $5.84 billion. Net-new ARR surged 51% to $333 million, a key metric that investors are closely watching.

Cash Flow and Stock Compensation

One of the counterarguments to the rally is the significant stock-based compensation (SBC) expense. In the latest quarter, SBC totaled $376.9 million, nearly equal to the reported free cash flow of $377 million and representing 25.6% of revenue. This raises questions about the quality of earnings, as GAAP net income was a mere $5.3 million. While free cash flow is a real metric, shareholders should be wary of treating it as costless owner earnings given the dilutive impact of equity awards.

Revenue Durability

Despite valuation concerns, CrowdStrike's revenue visibility is strong. Remaining performance obligations (RPO) stood at $10.7 billion as of July 31, with about 46% expected to be recognized over the next 12 months. Most subscription contracts are non-cancelable and range from one to three years, providing a solid contracted base that supports the premium valuation.

What's Next for Investors

The next critical test for CrowdStrike will be sustaining net-new ARR growth. If the company can continue to grow ARR at rates near the latest 51% while maintaining free cash flow margins, it could justify the current valuation. However, if ARR growth decelerates and SBC remains elevated, the stock may face downside risk. At $227, much of the good news embedded in the $250 target is already priced in, leaving little room for execution missteps.

Investors should monitor upcoming quarterly results for signs of continued momentum. The cybersecurity sector remains competitive, but CrowdStrike's leadership in cloud-delivered endpoint protection and its expanding product portfolio provide a solid foundation. As always, a balanced approach considering both growth prospects and valuation is prudent.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →